Olivera Marković

1.6k total citations
90 papers, 1.1k citations indexed

About

Olivera Marković is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Olivera Marković has authored 90 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 19 papers in Pathology and Forensic Medicine and 17 papers in Oncology. Recurrent topics in Olivera Marković's work include Lymphoma Diagnosis and Treatment (15 papers), Multiple Myeloma Research and Treatments (11 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Olivera Marković is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), Multiple Myeloma Research and Treatments (11 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Olivera Marković collaborates with scholars based in Serbia, United States and Indonesia. Olivera Marković's co-authors include Branka Filipović, Branislav Filipović, Dragomir Marisavljević, Milica C̆olović, Tatjana Srdić‐Rajić, Vladimir Jurišić, Gordana Konjević, Veselinka Šušić, J. Malcolm East and Robert F. Grimble and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and American Journal of Clinical Nutrition.

In The Last Decade

Olivera Marković

75 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivera Marković Serbia 16 221 183 172 159 151 90 1.1k
Liron Walsh United States 14 576 2.6× 226 1.2× 238 1.4× 245 1.5× 181 1.2× 24 1.5k
Viviènne Verweij Netherlands 21 301 1.4× 143 0.8× 94 0.5× 108 0.7× 101 0.7× 36 972
T Maekawa Japan 20 306 1.4× 226 1.2× 197 1.1× 379 2.4× 156 1.0× 87 1.2k
Angharad R. Morgan United Kingdom 23 428 1.9× 117 0.6× 128 0.7× 153 1.0× 202 1.3× 56 1.6k
Tarja Kunnas Finland 22 303 1.4× 42 0.2× 76 0.4× 132 0.8× 126 0.8× 68 1.2k
Bing Han China 17 278 1.3× 290 1.6× 61 0.4× 572 3.6× 117 0.8× 61 1.3k
Lijun Wu China 23 302 1.4× 95 0.5× 71 0.4× 147 0.9× 284 1.9× 113 1.6k
Takashi Ozaki Japan 29 376 1.7× 213 1.2× 60 0.3× 428 2.7× 154 1.0× 109 2.2k
Samy Sakkal Australia 22 355 1.6× 275 1.5× 40 0.2× 274 1.7× 512 3.4× 37 1.5k
Nicole Pezous Switzerland 11 248 1.1× 89 0.5× 174 1.0× 131 0.8× 807 5.3× 20 1.5k

Countries citing papers authored by Olivera Marković

Since Specialization
Citations

This map shows the geographic impact of Olivera Marković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivera Marković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivera Marković more than expected).

Fields of papers citing papers by Olivera Marković

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivera Marković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivera Marković. The network helps show where Olivera Marković may publish in the future.

Co-authorship network of co-authors of Olivera Marković

This figure shows the co-authorship network connecting the top 25 collaborators of Olivera Marković. A scholar is included among the top collaborators of Olivera Marković based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivera Marković. Olivera Marković is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cvetković, Zorica, et al.. (2025). Tumor Microenvironment, Inflammation, and Inflammatory Prognostic Indices in Diffuse Large B-Cell Lymphomas: A Narrative Review. International Journal of Molecular Sciences. 26(12). 5670–5670. 4 indexed citations
3.
Filipović, Branka, Miljan Milanović, Olivera Marković, et al.. (2025). A Closer Look into Autoimmune Liver Diseases. International Journal of Molecular Sciences. 26(5). 1863–1863.
4.
Cvetković, Zorica, et al.. (2024). Anemia and heart failure. 5(3). 370–381.
5.
Pavlović, Mirjana, et al.. (2022). A stem cell overview: From evolving hemobiological concepts to (auto)grafting in clinical practice. 3(2). 135–148. 1 indexed citations
6.
Stanisavljević, Nataša, Ljudmila Stojanovich, Aleksandra Djoković, et al.. (2022). Asymmetric Dimethylarginine Is a Marker of Endothelial Dysfunction in Thrombotic Antiphospholipid Syndrome Patients. International Journal of Molecular Sciences. 23(20). 12309–12309. 3 indexed citations
7.
Kovač, Mirjana, Gorana Mitić, Marija Milenković, et al.. (2022). Thrombosis risk assessment in patients with congenital thrombophilia during COVID - 19 infection. Thrombosis Research. 218. 151–156. 3 indexed citations
8.
Filipović, Branka, et al.. (2021). The Role of Psychotherapy in the Treatment of Patients with Non– alcoholic Fatty Liver Disease and Obstructive Sleep Apnea. Journal of Gastrointestinal and Liver Diseases. 30(4). 477–484. 2 indexed citations
9.
Mihaljević, Biljana, Jelena Jelicic, Bosko Andjelic, et al.. (2016). FCG (FLIPI, Charlson comorbidity index, and histological grade) score is superior to FLIPI in advanced follicular lymphoma. International Journal of Hematology. 104(6). 692–699. 7 indexed citations
10.
Marković, Olivera, et al.. (2014). Double-hit primary unilateral adrenal lymphoma with good outcome. Vojnosanitetski pregled. 71(7). 689–692. 2 indexed citations
11.
Marisavljević, Dragomir, et al.. (2014). BCL10 aberations and NF-kappa B activation involving p65 are absent or rare in primary gastric MALT lymphoma. Vojnosanitetski pregled. 71(11). 1040–1044. 3 indexed citations
12.
Radovanović, S., Ana Savić-Radojević, Tatjana Pekmezović, et al.. (2014). Uric Acid and Gamma-glutamyl Transferase Activity Are Associated With Left Ventricular Remodeling Indices in Patients With Chronic Heart Failure. Revista Española de Cardiología (English Edition). 67(8). 632–642. 10 indexed citations
13.
Marković, Olivera, et al.. (2010). Clinical and prognostic significance of apoptotic profile in patients with newly diagnosed nodal diffuse large B-cell lymphoma (DLBCL). European Journal Of Haematology. 86(3). 246–255. 20 indexed citations
14.
Bogdanović, Andrija, et al.. (2009). Poor outcome in patients with diffuse large B-cell lymphoma is associated with high percentage of bcl-2 and Ki 67-positive tumor cells. Vojnosanitetski pregled. 66(9). 738–743. 14 indexed citations
15.
Marković, Olivera, et al.. (2009). Sicca-Syndrom: Anamnese und Grundlagen der Therapie. Journal für Kardiologie (Krause & Pachernegg GmbH). 16(2). 67–71. 1 indexed citations
16.
Elezović, Ivo, et al.. (2009). Diffuse cavernous hemangioma of the left leg, vulva, uterus, and placenta of a pregnant woman. International Journal of Gynecology & Obstetrics. 107(3). 250–251. 18 indexed citations
17.
Jurišić, Vladimir, Tatjana Srdić‐Rajić, Gordana Konjević, Olivera Marković, & Milica C̆olović. (2007). Clinical stage-depending decrease of NK cell activity in multiple myeloma patients. Medical Oncology. 24(3). 312–317. 113 indexed citations
18.
Marisavljević, Dragomir, Cecilia Surace, Olivera Marković, et al.. (2006). A Ph-negative chronic myeloid leukemia with a complex BCR/ABL rearrangement and a t(6;9)(p21;q34.1). Cancer Genetics and Cytogenetics. 166(2). 180–185. 11 indexed citations
19.
Marković, Olivera, et al.. (1998). Cell cross-contamination in cell cultures: The silent and neglected danger. In Vitro Cellular & Developmental Biology - Animal. 34(1). 1–8. 73 indexed citations
20.
Marković, Olivera, et al.. (1994). A new assay for intracellular measurement of inosine monophosphate dehydrogenase activity: a guide for better selection of patients for enzyme-targeted chemotherapy.. Journal of Histochemistry & Cytochemistry. 42(1). 23–35. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liron Walsh Breakdown of academic impact, for papers by Viviènne Verweij Breakdown of academic impact, for papers by T Maekawa Breakdown of academic impact, for papers by Angharad R. Morgan Breakdown of academic impact, for papers by Tarja Kunnas Breakdown of academic impact, for papers by Bing Han Breakdown of academic impact, for papers by Lijun Wu Breakdown of academic impact, for papers by Takashi Ozaki Breakdown of academic impact, for papers by Samy Sakkal Breakdown of academic impact, for papers by Nicole Pezous
Rankless by CCL
2026